ID   PLA-802
AC   CVCL_AX34
SY   PLA 802; PLA802
DR   Cosmic; 2296988
DR   Wikidata; Q54947567
RX   CelloPub=CLPUB00322;
RX   PubMed=27008654;
CC   Population: Chinese.
CC   Doubling time: 42 hours (CelloPub=CLPUB00322).
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 6
//
RX   CelloPub=CLPUB00322;
RA   Chen L.-Z., Huang J.-X., You L.-B., Li H.-F.;
RT   "Establishment of human laryngeal alveolar rhabdomyosarcoma cell line
RT   (PLA-802) and observations on its biological properties.";
RL   Jie Fang Jun Yi Xue Za Zhi 8:249-252(1983).
//
RX   PubMed=27008654; DOI=10.1159/000443966;
RA   Yang H., Yuan Y., Luo C., He H.-X., Zhou Y.-D.;
RT   "Inhibitory effects of resveratrol on the human alveolar
RT   rhabdomyosarcoma cell line PLA-802 through inhibition of the
RT   TGF-beta1/Smad signaling pathway.";
RL   Pharmacology 98:35-41(2016).
//